PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY

Código QR

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY

We compared clinical efficacy and safety of simvastatin (40 mg daily) for 12 weeks (n = 33, group 1) vs fenofibrate (145 mg daily) for 12 weeks (n = 33, group 2) in patients with active RA taking stable doses of DMARDs. Changes in the Disease Activity Score (DAS28) with 28 joints count was the prima...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I. V. Shirinsky, N. Yu. Kalinovskaya, V. S. Shirinsky
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2019
Materias:	rheumatoid arthritis simvastatin fenofibrate das28 pleiotropic effect Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/58336e98a8784ef2be4d26bf0920e649
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

CLINICAL EFFICACY AND SAFETY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL CONTROLLED STUDY
por: V. S. Shirinsky, et al.
Publicado: (2014)

Pleiotropic effects of PPAR-α – from benchside to bedside
por: I. V. Shirinsky, et al.
Publicado: (2021)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
por: E. S. Zhugrova, et al.
Publicado: (2014)

EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

THE PRODUCTION OF PRO- AND ANTIINFLAMMATORY CYTOKINES BY SYNOVIAL FIBROBLASTS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN VITRO WHEN USING DNA METHYLATION MODULATORS - INVESTIGATIVE STUDY
por: M. A. Shnayder, et al.
Publicado: (2019)

CULTURES OF FIBROBLAST-LIKE SYNOVIAL CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS: PROPERTIES AND OPPORTUNITIES
por: M. A. Schneider, et al.
Publicado: (2016)

Migraine in patients with rheumatoid arthritis and its relation to disease activity
por: Hassan Abd-Elaty El-Sonbaty, et al.
Publicado: (2021)

Elevated APE1/Ref-1 Levels of Synovial Fluids in Patients with Rheumatoid Arthritis: Reflection of Disease Activity
por: In Seol Yoo, et al.
Publicado: (2021)

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
por: Nozaki Y, et al.
Publicado: (2018)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Y. Abramova, et al.
Publicado: (2014)

Clinical utility of quantitative analysis of bone scintigraphy in detecting clinically active joint and high disease activity in patients with rheumatoid arthritis
por: Jeong Won Lee, et al.
Publicado: (2021)

TELOMERE SHORTENING IN MONOCYTES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: V. I. Borisov, et al.
Publicado: (2014)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
por: I. B. Belyaeva, et al.
Publicado: (2014)

HETEROGENEITY OF POLYCLONAL IMMUNOGLOBULINS NUCLEASE ACTIVITY IN RHEUMATOID AND REACTIVE ARTHRITIS
por: M. V. Volkova, et al.
Publicado: (2017)

Lower Urinary Tract Symptoms Among Females with Rheumatoid Arthritis: A Prospective Cross-Sectional Study
por: Abushamma F, et al.
Publicado: (2021)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
por: V. V. Sokolova, et al.
Publicado: (2014)

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2014)

Risk of cervical myelopathy in rheumatoid arthritis patients with neck pain
por: Marina W. Gerges, et al.
Publicado: (2022)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

INFLUENCE OF HERPES SIMPLEX VIRUS PERSISTENCE UPON PRODUCTION OF CYTOKINES BY IMMUNOCOMPETENT CELLS IN RHEUMATOID ARTHRITIS
por: N. A. Pronina, et al.
Publicado: (2014)

Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
por: Fischer PA, et al.
Publicado: (2018)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
por: I. A. Orlovskaya, et al.
Publicado: (2015)

SUBTYPE CHARACTERICS OF DENDRITIC CELLS FROM PERIPHERAL BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
por: S. A. Falaleeva, et al.
Publicado: (2014)

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Extra‐articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement
por: Razvan M. Chirila, et al.
Publicado: (2021)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Jianan Zhao, et al.
Publicado: (2021)

Clinical utility of anti-carbamylated antibody in rheumatoid arthritis female patients: Emerging predictive value compared to anti-cyclic citrullinated peptide and rheumatoid factor
por: Ahmed E. Hafez, et al.
Publicado: (2022)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021)

STUDIES OF SEVERAL BLOOD CYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL AND IMMUNOLOGAL INTERRRELATIONS
por: M. V. Pachkunova, et al.
Publicado: (2014)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: A. N. Silkov, et al.
Publicado: (2014)

ALPHA–2–MACROGLOBULIN COMPLEXES WITH IGG ANTIBODIES, PLASMIN, AND THEIR INTERRELATION WITH OTHER FACTORS OF HUMORAL IMMUNITY DURING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
por: V. N. Zorina, et al.
Publicado: (2014)

MOLECULAR BIOLOGY ANALYSIS OF IL -1Β, IL -4, AND IL -1Β RA GENE POLYMORPHISMS IN ETHNIC BASHKIR PATIENTS WITH RHEUMATOID ARTHRITIS, LIVING IN C HELYABINSK REGION
por: A. L. Burmistrova, et al.
Publicado: (2014)

Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis
por: Jianlin Zuo, et al.
Publicado: (2021)

Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis
por: Durán,Josefina, et al.
Publicado: (2019)

CLINICAL IMPORTANCE OF DETERMINATION OF HLA-DRB1 LOCUS GENES IN RHEUMATOID ARTHRITIS
por: V. Guseva, et al.
Publicado: (2019)